 Alkesh Jani
Concepts (255)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Transplantation | 12 | 2021 | 560 | 3.510 |
Why?
| | Cold Ischemia | 7 | 2021 | 28 | 3.260 |
Why?
| | Apoptosis | 14 | 2021 | 2377 | 2.440 |
Why?
| | Organ Preservation | 5 | 2018 | 68 | 2.330 |
Why?
| | Kidney | 15 | 2021 | 1208 | 2.310 |
Why?
| | Acute Kidney Injury | 11 | 2021 | 647 | 2.070 |
Why?
| | Hibernation | 6 | 2016 | 72 | 1.900 |
Why?
| | Kidney Tubules | 5 | 2016 | 107 | 1.570 |
Why?
| | Caspase Inhibitors | 3 | 2018 | 78 | 1.360 |
Why?
| | Sciuridae | 4 | 2016 | 142 | 1.230 |
Why?
| | Reperfusion Injury | 4 | 2021 | 257 | 1.150 |
Why?
| | Caspase 3 | 8 | 2018 | 237 | 1.140 |
Why?
| | Necrosis | 4 | 2021 | 211 | 1.110 |
Why?
| | Delayed Graft Function | 3 | 2018 | 26 | 1.060 |
Why?
| | Rewarming | 2 | 2016 | 16 | 1.020 |
Why?
| | Caspase 1 | 4 | 2021 | 141 | 0.930 |
Why?
| | Autophagy | 4 | 2016 | 236 | 0.930 |
Why?
| | Warm Ischemia | 2 | 2020 | 11 | 0.840 |
Why?
| | Ischemia | 6 | 2020 | 363 | 0.820 |
Why?
| | Mice, Inbred C57BL | 17 | 2021 | 4769 | 0.720 |
Why?
| | Organ Preservation Solutions | 2 | 2018 | 42 | 0.720 |
Why?
| | Inhibitor of Apoptosis Proteins | 2 | 2016 | 42 | 0.660 |
Why?
| | Cold Temperature | 3 | 2016 | 127 | 0.660 |
Why?
| | Toll-Like Receptor 4 | 1 | 2021 | 288 | 0.650 |
Why?
| | Amino Acid Chloromethyl Ketones | 1 | 2018 | 22 | 0.640 |
Why?
| | Quinolines | 1 | 2018 | 129 | 0.590 |
Why?
| | Animals | 30 | 2021 | 32123 | 0.570 |
Why?
| | Nephrectomy | 4 | 2018 | 150 | 0.540 |
Why?
| | Thiones | 1 | 2015 | 14 | 0.530 |
Why?
| | Arteriovenous Anastomosis | 1 | 2015 | 13 | 0.520 |
Why?
| | Vascular Surgical Procedures | 2 | 2015 | 262 | 0.520 |
Why?
| | Mice | 19 | 2021 | 15075 | 0.510 |
Why?
| | Renal Artery | 1 | 2015 | 26 | 0.510 |
Why?
| | Aorta, Abdominal | 1 | 2015 | 39 | 0.510 |
Why?
| | Pyrimidinones | 1 | 2015 | 86 | 0.500 |
Why?
| | Microsurgery | 1 | 2015 | 61 | 0.490 |
Why?
| | Arousal | 2 | 2012 | 153 | 0.480 |
Why?
| | Models, Animal | 4 | 2020 | 350 | 0.470 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2016 | 399 | 0.460 |
Why?
| | Renin-Angiotensin System | 1 | 2013 | 72 | 0.440 |
Why?
| | Disease Models, Animal | 5 | 2020 | 3582 | 0.430 |
Why?
| | Creatinine | 4 | 2020 | 431 | 0.410 |
Why?
| | Reperfusion | 1 | 2011 | 40 | 0.400 |
Why?
| | Blood Proteins | 1 | 2012 | 238 | 0.350 |
Why?
| | Adaptation, Physiological | 1 | 2013 | 476 | 0.350 |
Why?
| | Body Temperature | 3 | 2013 | 211 | 0.300 |
Why?
| | Male | 19 | 2021 | 56128 | 0.260 |
Why?
| | Cisplatin | 4 | 2015 | 263 | 0.260 |
Why?
| | Tissue Donors | 3 | 2021 | 331 | 0.250 |
Why?
| | Cysteine Proteinase Inhibitors | 1 | 2004 | 45 | 0.240 |
Why?
| | Kidney Failure, Chronic | 2 | 2008 | 491 | 0.230 |
Why?
| | Interleukin-18 | 3 | 2013 | 222 | 0.220 |
Why?
| | Gene Expression Regulation | 1 | 2012 | 2362 | 0.220 |
Why?
| | Thiamine Deficiency | 1 | 2022 | 8 | 0.210 |
Why?
| | Swine | 2 | 2015 | 706 | 0.210 |
Why?
| | Acidosis, Lactic | 1 | 2022 | 29 | 0.210 |
Why?
| | Signal Transduction | 5 | 2021 | 4526 | 0.210 |
Why?
| | Renal Circulation | 3 | 2015 | 54 | 0.210 |
Why?
| | Seasons | 3 | 2015 | 458 | 0.200 |
Why?
| | Glomerular Filtration Rate | 2 | 2012 | 605 | 0.180 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2020 | 73 | 0.180 |
Why?
| | Interleukin-8 | 2 | 2013 | 243 | 0.170 |
Why?
| | Mice, Knockout | 4 | 2021 | 2606 | 0.170 |
Why?
| | Caspases | 3 | 2013 | 245 | 0.170 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2011 | 249 | 0.170 |
Why?
| | Cytokines | 5 | 2015 | 1857 | 0.170 |
Why?
| | Cells, Cultured | 3 | 2016 | 3916 | 0.160 |
Why?
| | Graft Rejection | 1 | 2002 | 533 | 0.160 |
Why?
| | Kidney Tubular Necrosis, Acute | 2 | 2011 | 22 | 0.160 |
Why?
| | Epithelial Cells | 3 | 2014 | 965 | 0.160 |
Why?
| | Perfusion | 2 | 2011 | 152 | 0.150 |
Why?
| | Alcoholism | 1 | 2022 | 717 | 0.130 |
Why?
| | LLC-PK1 Cells | 1 | 2015 | 16 | 0.130 |
Why?
| | Cytoprotection | 1 | 2015 | 53 | 0.130 |
Why?
| | Transfection | 2 | 2016 | 866 | 0.130 |
Why?
| | AMP Deaminase | 1 | 2015 | 9 | 0.130 |
Why?
| | Biological Assay | 1 | 2016 | 114 | 0.130 |
Why?
| | Renal Artery Obstruction | 1 | 2015 | 30 | 0.130 |
Why?
| | Transplants | 1 | 2015 | 37 | 0.130 |
Why?
| | Anastomosis, Surgical | 1 | 2015 | 141 | 0.120 |
Why?
| | Phosphorylation | 2 | 2016 | 1561 | 0.120 |
Why?
| | Species Specificity | 1 | 2016 | 555 | 0.120 |
Why?
| | Immunohistochemistry | 2 | 2012 | 1643 | 0.120 |
Why?
| | Macrolides | 1 | 2014 | 56 | 0.120 |
Why?
| | Cell Line | 2 | 2018 | 2655 | 0.120 |
Why?
| | Phenanthrenes | 1 | 2014 | 10 | 0.120 |
Why?
| | Antineoplastic Agents | 3 | 2014 | 1891 | 0.120 |
Why?
| | Diterpenes | 1 | 2014 | 32 | 0.120 |
Why?
| | RNA Interference | 1 | 2016 | 438 | 0.120 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2015 | 175 | 0.110 |
Why?
| | Biomarkers | 4 | 2018 | 3474 | 0.110 |
Why?
| | Physiology, Comparative | 1 | 2013 | 3 | 0.110 |
Why?
| | Ursidae | 1 | 2012 | 7 | 0.110 |
Why?
| | Acute-Phase Proteins | 1 | 2013 | 64 | 0.110 |
Why?
| | Lipocalins | 1 | 2013 | 34 | 0.110 |
Why?
| | Nephrology | 1 | 2012 | 48 | 0.100 |
Why?
| | Blotting, Western | 2 | 2012 | 1153 | 0.100 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2015 | 965 | 0.100 |
Why?
| | alpha-Macroglobulins | 1 | 2012 | 24 | 0.100 |
Why?
| | Thrombosis | 1 | 2015 | 302 | 0.100 |
Why?
| | Serum Albumin | 1 | 2012 | 135 | 0.100 |
Why?
| | Raffinose | 1 | 2011 | 20 | 0.100 |
Why?
| | Adipose Tissue | 1 | 2015 | 553 | 0.100 |
Why?
| | Hemodynamics | 1 | 2015 | 970 | 0.090 |
Why?
| | DNA Primers | 1 | 2012 | 513 | 0.090 |
Why?
| | bcl-X Protein | 1 | 2011 | 39 | 0.090 |
Why?
| | Allopurinol | 1 | 2011 | 55 | 0.090 |
Why?
| | Sus scrofa | 1 | 2011 | 45 | 0.090 |
Why?
| | Chromatography, Liquid | 1 | 2012 | 346 | 0.090 |
Why?
| | Tissue and Organ Harvesting | 1 | 2011 | 69 | 0.090 |
Why?
| | Macrophages | 3 | 2013 | 1281 | 0.090 |
Why?
| | Polycystic Kidney Diseases | 1 | 2011 | 55 | 0.090 |
Why?
| | Death | 1 | 2011 | 107 | 0.090 |
Why?
| | Chemokine CXCL1 | 4 | 2012 | 66 | 0.090 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 934 | 0.090 |
Why?
| | Tandem Mass Spectrometry | 1 | 2012 | 416 | 0.090 |
Why?
| | Interleukins | 1 | 2011 | 237 | 0.090 |
Why?
| | Metabolic Syndrome | 1 | 2013 | 323 | 0.090 |
Why?
| | Treatment Outcome | 3 | 2015 | 9166 | 0.080 |
Why?
| | Glutathione | 1 | 2011 | 303 | 0.080 |
Why?
| | Proto-Oncogene Proteins | 1 | 2013 | 609 | 0.080 |
Why?
| | Carrier Proteins | 1 | 2013 | 703 | 0.080 |
Why?
| | Adenosine | 1 | 2011 | 204 | 0.080 |
Why?
| | Dendritic Cells | 1 | 2012 | 436 | 0.080 |
Why?
| | Receptors, Interleukin-8B | 1 | 2008 | 23 | 0.080 |
Why?
| | Cyst Fluid | 1 | 2008 | 27 | 0.080 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2012 | 488 | 0.070 |
Why?
| | Postoperative Complications | 2 | 2015 | 2167 | 0.070 |
Why?
| | Kidney Diseases | 2 | 2008 | 355 | 0.070 |
Why?
| | Kidney Glomerulus | 2 | 2011 | 102 | 0.070 |
Why?
| | Cysts | 1 | 2008 | 94 | 0.070 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2008 | 351 | 0.070 |
Why?
| | Proteomics | 1 | 2012 | 855 | 0.070 |
Why?
| | Liver Transplantation | 1 | 2013 | 830 | 0.060 |
Why?
| | Liver Diseases | 1 | 2008 | 263 | 0.060 |
Why?
| | Liver | 2 | 2015 | 1693 | 0.060 |
Why?
| | Humans | 13 | 2022 | 115908 | 0.060 |
Why?
| | Thermosensing | 1 | 2004 | 10 | 0.060 |
Why?
| | Kidney Cortex | 1 | 2004 | 23 | 0.060 |
Why?
| | Caspase 2 | 1 | 2004 | 14 | 0.060 |
Why?
| | Caspase 8 | 1 | 2004 | 43 | 0.060 |
Why?
| | DNA Fragmentation | 1 | 2004 | 47 | 0.060 |
Why?
| | Caspase 9 | 1 | 2004 | 48 | 0.060 |
Why?
| | Kidney Function Tests | 2 | 2015 | 141 | 0.060 |
Why?
| | Polycystic Kidney, Autosomal Dominant | 1 | 2008 | 209 | 0.060 |
Why?
| | Microvilli | 1 | 2004 | 70 | 0.060 |
Why?
| | In Situ Nick-End Labeling | 1 | 2004 | 119 | 0.060 |
Why?
| | Calpain | 1 | 2004 | 53 | 0.060 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 2 | 2015 | 262 | 0.060 |
Why?
| | Acute Disease | 2 | 2008 | 917 | 0.060 |
Why?
| | Scleroderma, Systemic | 1 | 2004 | 97 | 0.060 |
Why?
| | Immunoblotting | 1 | 2004 | 283 | 0.060 |
Why?
| | Pancreas Transplantation | 1 | 2003 | 64 | 0.050 |
Why?
| | Calcineurin Inhibitors | 1 | 2003 | 59 | 0.050 |
Why?
| | Thiamine | 1 | 2022 | 11 | 0.050 |
Why?
| | Neoplasms | 1 | 2015 | 2112 | 0.050 |
Why?
| | Sirolimus | 1 | 2003 | 192 | 0.050 |
Why?
| | Temperature | 1 | 2004 | 590 | 0.050 |
Why?
| | Insulin | 1 | 2011 | 2083 | 0.050 |
Why?
| | Food | 1 | 2022 | 160 | 0.050 |
Why?
| | Neutrophil Infiltration | 2 | 2013 | 95 | 0.050 |
Why?
| | Cell Proliferation | 1 | 2008 | 2196 | 0.050 |
Why?
| | Reference Values | 1 | 2002 | 745 | 0.050 |
Why?
| | Interleukin-1beta | 2 | 2013 | 370 | 0.040 |
Why?
| | Risk Factors | 2 | 2013 | 8714 | 0.040 |
Why?
| | TRPP Cation Channels | 2 | 2011 | 63 | 0.040 |
Why?
| | Time Factors | 2 | 2004 | 6186 | 0.040 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 794 | 0.040 |
Why?
| | Flow Cytometry | 2 | 2011 | 1059 | 0.030 |
Why?
| | Gene Knockout Techniques | 1 | 2015 | 99 | 0.030 |
Why?
| | Lymphocyte Depletion | 1 | 2015 | 115 | 0.030 |
Why?
| | Peroxidase | 1 | 2015 | 157 | 0.030 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2015 | 146 | 0.030 |
Why?
| | Homozygote | 1 | 2015 | 186 | 0.030 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2015 | 157 | 0.030 |
Why?
| | Tumor Burden | 1 | 2015 | 261 | 0.030 |
Why?
| | Adult | 5 | 2013 | 30820 | 0.030 |
Why?
| | Endothelial Cells | 2 | 2011 | 694 | 0.030 |
Why?
| | MAP Kinase Kinase 4 | 1 | 2014 | 23 | 0.030 |
Why?
| | Epoxy Compounds | 1 | 2014 | 31 | 0.030 |
Why?
| | Cell Line, Tumor | 2 | 2013 | 2749 | 0.030 |
Why?
| | Interleukin-1alpha | 1 | 2013 | 55 | 0.030 |
Why?
| | Uremia | 1 | 2012 | 14 | 0.030 |
Why?
| | Obesity, Abdominal | 1 | 2013 | 38 | 0.030 |
Why?
| | Lipocalin-2 | 1 | 2013 | 62 | 0.030 |
Why?
| | Middle Aged | 4 | 2013 | 27084 | 0.030 |
Why?
| | Kidney Tubules, Proximal | 1 | 2013 | 113 | 0.030 |
Why?
| | Cholesterol, HDL | 1 | 2013 | 185 | 0.030 |
Why?
| | MAP Kinase Signaling System | 1 | 2014 | 274 | 0.030 |
Why?
| | Clodronic Acid | 1 | 2012 | 8 | 0.030 |
Why?
| | Fatty Acids | 1 | 2015 | 385 | 0.030 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2013 | 145 | 0.030 |
Why?
| | Lipid Metabolism | 1 | 2015 | 449 | 0.030 |
Why?
| | Thromboembolism | 1 | 2012 | 93 | 0.030 |
Why?
| | Female | 4 | 2013 | 60086 | 0.030 |
Why?
| | Diphtheria Toxin | 1 | 2012 | 51 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2015 | 933 | 0.020 |
Why?
| | Chemokine CCL2 | 1 | 2012 | 106 | 0.020 |
Why?
| | Computer Simulation | 1 | 2016 | 887 | 0.020 |
Why?
| | Interleukin-33 | 1 | 2011 | 40 | 0.020 |
Why?
| | Cholesterol, LDL | 1 | 2013 | 309 | 0.020 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2012 | 139 | 0.020 |
Why?
| | Beclin-1 | 1 | 2011 | 9 | 0.020 |
Why?
| | Triglycerides | 1 | 2013 | 470 | 0.020 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2011 | 138 | 0.020 |
Why?
| | Wound Healing | 1 | 2012 | 263 | 0.020 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2011 | 175 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2011 | 399 | 0.020 |
Why?
| | Glucose | 1 | 2015 | 904 | 0.020 |
Why?
| | Osteoporosis | 1 | 2012 | 227 | 0.020 |
Why?
| | Microtubule-Associated Proteins | 1 | 2011 | 176 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2012 | 1165 | 0.020 |
Why?
| | Colorado | 2 | 2013 | 4122 | 0.020 |
Why?
| | Blood Urea Nitrogen | 1 | 2008 | 51 | 0.020 |
Why?
| | CD11b Antigen | 1 | 2008 | 58 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2013 | 1728 | 0.020 |
Why?
| | Chemokine CXCL5 | 1 | 2008 | 12 | 0.020 |
Why?
| | Comorbidity | 1 | 2013 | 1476 | 0.020 |
Why?
| | Cell Shape | 1 | 2008 | 54 | 0.020 |
Why?
| | Cell Count | 1 | 2008 | 304 | 0.020 |
Why?
| | Estradiol | 1 | 2011 | 453 | 0.020 |
Why?
| | Interleukin-1 | 1 | 2012 | 971 | 0.020 |
Why?
| | Chemokines | 1 | 2008 | 214 | 0.020 |
Why?
| | Cell Polarity | 1 | 2008 | 131 | 0.020 |
Why?
| | Cell Hypoxia | 1 | 2008 | 220 | 0.020 |
Why?
| | Blood Pressure | 1 | 2013 | 1536 | 0.020 |
Why?
| | Incidence | 1 | 2013 | 2333 | 0.020 |
Why?
| | Stress, Mechanical | 1 | 2008 | 440 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2013 | 2814 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2013 | 1078 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2013 | 2209 | 0.010 |
Why?
| | Cadaver | 1 | 2004 | 316 | 0.010 |
Why?
| | Muscle, Skeletal | 1 | 2012 | 1459 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2008 | 1129 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2008 | 1970 | 0.010 |
Why?
| | Hospitals, University | 1 | 2003 | 172 | 0.010 |
Why?
| | Cyclosporine | 1 | 2003 | 169 | 0.010 |
Why?
| | Rats | 1 | 2011 | 5035 | 0.010 |
Why?
| | Graft Survival | 1 | 2004 | 481 | 0.010 |
Why?
| | Tacrolimus | 1 | 2003 | 143 | 0.010 |
Why?
| | Living Donors | 1 | 2004 | 324 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2008 | 1318 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2013 | 6438 | 0.010 |
Why?
| | Survival Analysis | 1 | 2004 | 1221 | 0.010 |
Why?
| | Aged | 2 | 2013 | 19299 | 0.010 |
Why?
| | Skin | 1 | 2004 | 668 | 0.010 |
Why?
| | Drug Therapy, Combination | 1 | 2003 | 961 | 0.010 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2008 | 2020 | 0.010 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2013 | 2091 | 0.010 |
Why?
| | Immunosuppressive Agents | 1 | 2003 | 666 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2003 | 1868 | 0.010 |
Why?
| | Young Adult | 1 | 2013 | 10518 | 0.010 |
Why?
| | Retrospective Studies | 2 | 2004 | 12616 | 0.010 |
Why?
| | Adolescent | 1 | 2013 | 17955 | 0.010 |
Why?
| | United States | 1 | 2004 | 12338 | 0.000 |
Why?
|
|
Jani's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|